Fig. 3 | Signal Transduction and Targeted Therapy

Fig. 3

From: Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein

Fig. 3

Antigenic cross-reaction between rVSV-SARS-CoV and rVSV-SARS-CoV-2. a, b Neutralization curves of sera from (Fig. 2k, l) against rVSV-eGFP-SARS-CoV-2 and rVSV-eGFP-SARS-CoV. c, d S RBD specific IgG in the sera from rVSV-SARS-CoV-2, rVSV-SARS-CoV or mock immunized hACE2 mice (Con.) was determined by ELISA with captured SARS-CoV-2 S RBD (c) or SARS-CoV S RBD (d). Error bars in a, b, c, d indicate standard deviation of the mean

Back to article page